Asya Shtofmakher
Physician Assistant · New York, NYNPI 1033662473
Payments from drug & device makers
Across 601 payments — averaging $26.44 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$3K
- Boston Scientific$3K
- Collegium Pharmaceutical, Inc.$2K
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$2K
- MML US, Inc.$1K
- AbbVie$1K
- plus $4K from 27 others
Across 2 payments — averaging $1990.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$4K
What the payments were for
- Food & beverage$15,864100%
- Education$260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 66 | $3,337 |
| Boston Scientific | 49 | $2,661 |
| Collegium Pharmaceutical, Inc. | 97 | $1,696 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 109 | $1,564 |
| MML US, Inc. | 48 | $1,234 |
| AbbVie(2 entities) | 48 | $1,145 |
| Amgen(2 entities) | 49 | $1,061 |
| Forte Bio-pharma LLC | 15 | $355 |
| Sanara Medtech Inc. | 2 | $347 |
| Pfizer | 13 | $320 |
| Kowa Pharmaceuticals America, Inc. | 11 | $255 |
| Galderma Laboratories, L.p. | 11 | $233 |
| Protega Pharmaceutials Inc | 11 | $213 |
| Scilex Pharmaceuticals Inc. | 12 | $197 |
| Tersera Therapeutics LLC | 9 | $193 |
| Abbott | 3 | $140 |
| Supernus Pharmaceuticals, Inc. | 10 | $115 |
| Biodelivery Sciences International, Inc. | 5 | $89 |
| Valinor Pharma, LLC | 4 | $83 |
| Tonix Medicines, Inc. | 2 | $73 |
| GRT US Holding, Inc. | 3 | $71 |
| Novartis | 2 | $65 |
| Redhill Biopharma Inc. | 3 | $63 |
| Almatica Pharma LLC | 3 | $61 |
| Relievant Medsystems, Inc. | 3 | $49 |
| Si-bone, Inc. | 1 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $47 |
| Hikma Pharmaceuticals USA | 3 | $46 |
| Merz Pharmaceuticals, LLC | 2 | $42 |
| IBSA Pharma Inc. | 2 | $34 |
| Indivior Inc. | 1 | $21 |
| Merz North America, Inc. | 1 | $18 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SYNCHROMEDII$1,375
- WaveWriter Alpha Prime 16$1,301
- ReActiv8$388
- CellerateRx$347
- INTELLIS$294
- INCEPTIV$273
- GENERAL PAIN MANAGEMENT$261
- RELISTOR$221
- Superion Indirect Decompression System$170
- Intracept$160
- Vanta$152
- INTELLIS ADAPTIVESTIM$149
- SPECTRA WAVEWRITER$140
- SYNCHROMED$132
How this compares
$15,889 in reported general payments places this provider in the 95th percentile of 11,358 physician assistant providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RoxybondOxycodone Hcl | 71 | $130,383 |
| RelistorMethylnaltrexone Bromide | 42 | $107,391 |
| OxycontinOxycodone Hcl | 92 | $104,999 |
| Xtampza ErOxycodone Myristate | 89 | $74,430 |
| BelbucaBuprenorphine Hcl | 85 | $65,566 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 747 | $53,114 |
| Nurtec OdtRimegepant Sulfate | 25 | $46,741 |
| Nucynta ErTapentadol Hcl | 44 | $46,345 |
| MovantikNaloxegol Oxalate | 76 | $33,782 |
| DuexisIbuprofen/Famotidine | 12 | $28,902 |
| NucyntaTapentadol Hcl | 25 | $27,566 |
| Oxycodone Hcl | 1,170 | $21,780 |
| Diclofenac Sodium | 97 | $16,862 |
| Aimovig AutoinjectorErenumab-Aooe | 14 | $15,975 |
| Lidocaine | 110 | $15,619 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Collegium Pharmaceutical, Inc.Xtampza Er, Belbuca, Nucynta Er, Nucynta | $1,696 | $213,908243 claims |
| Protega Pharmaceutials IncRoxybond | $213 | $130,38371 claims |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,564 | $107,39142 claims |
| PfizerNurtec Odt | $320 | $46,74125 claims |
| Redhill Biopharma Inc.Movantik | $63 | $33,78276 claims |
| AmgenDuexis | $1,061 | $28,90212 claims |
| Hikma Pharmaceuticals USAMorphine Sulfate, Buprenorphine | $46 | $11,596248 claims |
| Forte Bio-pharma LLCProlate | $355 | $9,90313 claims |
| AbbVieLinzess | $1,145 | $7,01713 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 11,358 physician assistant providers in New York.
Other physician assistant in New York
- Kristyl Cuenca-SiskoNew York$478K
- Cameron KiserNew York$225K
- Mervat FalahNew York$143K
- Marlene TaylorNew York$109K
- Natalie TafelNew York$77K
- Edwin CalderonNew York$59K
- Jonathan YehNew York$57K
- Emily ElbogenNew York$49K
- Jaclyn ChurchillNew York$48K
- Russell BrandweinNew York$44K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.